This Semiconductor ETF Soars 54% This Year, Excludes Intel
A fabless chip ETF is up sharply this year, powered by AI-driven design firms and a deliberate omission of Intel. The...
Which Cash Back Cards Offer The Best Options 2023
Find out which cash back cards offer the best options for 2023. Stay updated with the latest offerings to maximize your rewards.
26,992 articles
Snowflake’s Billion Data Starting Gains Momentum Now
Snowflake reports a sizable rise in remaining performance obligations, underscoring a strengthening data-backlog thes...
Price Prediction: ASML Could Reach New Highs on AI Demand
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...
Toronto-Dominion Bank Could Soar If 3 Key Alignments
TD Bank has been on investors' radars, but sustained upside hinges on three core drivers. Explore how regulatory shif...
Photo Marco Rubio Wearing Oversized Shoes Goes Viral
A single photo can trigger a flood of online chatter and real-world money decisions. This piece breaks down what a vi...
Bill Ackman Been Quietly Accumulating Microsoft Stock
Pershing Square’s bill ackman been quietly building a Microsoft stake since February signals a patient, long-term bet...
Stock Market Doing Something Unprecedented, Take Note
Observers are seeing the stock market doing something rarely seen: broad gains across the DJIA, S&P 500, and Nasdaq a...
AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Higher-For-Longer Rates Gift Life: MetLife and Prudential
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...
Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Bunge Stock Could $134 by Year End, JPMorgan Analyst Says
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Citi Cuts Lucid Price Target as Q1 Miss Rocks Shares
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status